TriangleCoriolus Versicolor Extract (NCT06450873)
Coriolus Versicolor Extract trial for Estrogen Receptor-Positive Breast Carcinoma (NCT06450873). This is a short film with English narration. The transcript is on this page, and the written brief is separate.
What the film says
Read the transcript
This trial is for postmenopausal adult women with newly diagnosed ER-positive, HER2-negative breast cancer scheduled for surgery. Tumor Ki-67 must be at least 10%, with a lesion larger than five millimeters. Metastatic disease is excluded.
The idea: take turkey-tail mushroom extract twice daily for 20–42 days before surgery. It may affect immune activity, but its precise mechanism is unknown. Researchers compare the Ki-67 growth marker before and after treatment and assess side effects.
This phase 2 study plans 40 patients. Brenda Ernst leads at Mayo Clinic in Scottsdale, the sole recruiting US site.
Public record; not medical advice.
Already in a trial?
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.